Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 20, Number 6—June 2014
Research

Rapid Spread and Diversification of Respiratory Syncytial Virus Genotype ON1, Kenya

Charles N. AgotiComments to Author , James R. Otieno, Caroline W. Gitahi, Patricia A. Cane, and D. James Nokes
Author affiliations: Kenya Medical Research Institute–Wellcome Trust Research Programme, Kilifi, Kenya (C.N. Agoti, J.R. Otieno, C.W. Gitahi, D.J. Nokes); Public Health England, London, UK (P.A. Cane); University of Warwick and WIDER, Coventry, UK (D.J. Nokes)

Main Article

Table 1

Occurrence of RSV group A and B viruses and of genotype ON1 in Kilifi, Kenya, 2012*

Month No. RSV strains detected
RSV group A sequencing result
Group A Group B Co-infected (A+B) Total No. (%) ON1 strains† Non-ON1 Not sequenced
First wave
Jan 0 18 0 18 0 0 0
Feb 6 23 0 29 1 (20.0) 4 1
Mar 15 26 1 42 8 (53.3) 7 1
Apr 14 16 1 31 5 (41.7) 7 3
May 4 6 0 10 3 (100.0) 0 1
Jun 11 2 0 13 9 (81.8) 2 0
Jul 3 0 0 3 3 (100.0) 0 0
Aug
2
0
0
2

2 (100.0)
0
0
Non-wave period
Sep
0
1
0
1

0
0
0
Second wave
Oct 7 1 0 8 4 (66.7) 2 1
Nov 38 16 1 55 31 (91.2) 3 5
Dec‡
23
5
0
28

11 (84.6)
2
10
Total 123 114 3 240 77 (74.0) 27 21

*The calendar year 2012 spans parts of 2 epidemics: the 2011–12 epidemic, which occurred during October 2011–August 2012 (peak March 2012), and the 2012–13 epidemic, which occurred during October 2012–July 2013 (peak November 2012). Group B RSVs predominated during the 2011–12 epidemic (65.0%), and group A RSVs predominated during the 2012–13 epidemic (79.28%). RSV, respiratory syncytial virus.
†Percentages represent the proportion of ON1 viruses among RSV A sequenced samples from each month.
‡Because of local logistics problems, samples were not collected from all the subjects that were eligible in December.

Main Article

Page created: May 16, 2014
Page updated: May 16, 2014
Page reviewed: May 16, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external